Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

Two-drug combos built around amlodipine control BP in African study

In the largest-ever randomized trial of antihypertensive drug treatment in sub-Saharan Africa, two medication combinations including the long-acting calcium channel blocker amlodipine outperformed a third two-drug combination featuring a diuretic and an angiotensin-converting-enzyme (ACE) inhibitor.

Thumbnail

Renal denervation sustains BP reduction for 6 months in sham-controlled trial

Hypertensive patients from the RADIANCE-HTN SOLO trial who received renal denervation sustained a lower blood pressure through six months compared to participants randomized to a sham procedure, despite being placed on fewer antihypertensive medications during follow-up.

Thumbnail

REDUCE-IT shows 30% drop in total MACE with icosapent ethyl

NEW ORLEANS — A new analysis considering not only a patient's first cardiovascular event—but the second, third and beyond—paints the REDUCE-IT trial in an even more positive light. 

Thumbnail

Diabetes, hypertension cause 64% of end-stage kidney disease cases

The CDC has released a new fact sheet on the burden of chronic kidney disease (CKD) in the U.S., highlighting its relationship to cardiovascular disease and noting that 15 percent of American adults—or 37 million people—have CKD.

FDA speeds approval for generic valsartan amid shortage

The FDA fast-tracked the approval process for a new generic valsartan product (Diovan) amid an ongoing shortage of the blood pressure and heart failure medication.

Thumbnail

Napping tied to 5 mm Hg drop in systolic blood pressure

A napping habit could lower blood pressure to a similar extent as other lifestyle modifications and some drugs, according to research scheduled to be presented March 18 at the American College of Cardiology’s scientific sessions in New Orleans.

Thumbnail

SPRINT analysis: Intensive BP lowering could be harmful for smokers

The SPRINT trial suggested a more aggressive blood pressure-lowering target reduced the rate of cardiovascular events in hypertensive people, but a new secondary analysis of the trial indicates such an approach may actually be harmful for smokers.

Thumbnail

Smartphone app detects diabetes with ‘reasonable discrimination’

A smartphone’s camera and flashlight features can detect changes in blood flow and identify type 2 diabetes with accuracy comparable to traditional, clinic-based risk scores, new research suggests.